INS and cancer: Further studies have compared metformin therapy to other anti-diabetic therapies and found that while diabetics had an increased cancer mortality compared to non-diabetics, those on metformin had a lower cancer mortality compared to those taking other anti-diabetic medications such as sulfonylureas or insulin [4, 28].